University of Miami, Sylvester Comprehensive Cancer Center

Site:	University of Miami, Sylvester Comprehensive Cancer Center	Go to their website
Address:	1475 Northwest 12th Ave
City:	Miami
State:	FL
Zip:	33136
Country:	USA

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
1/2	A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)	Recruiting	Active	DCC-3009	NCT06630234
2	ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST	Recruiting	Active	ctDNA plus Sunitinib or Regorafenib	NCT05366816
2	KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting	Recruiting	Active	KQB198 + Imatinib	NCT07406633
1	A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit	Recruiting	Active	NN3201	NCT06805825
1	A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)	Recruiting	Active	Ziftomenib + Imatinib	NCT06655246
1	Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma	Suspended	Closed	Dendritic Cell Vaccine	NCT01803152
3	A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment	Terminated	Active	Masitinib, (AB1010)	NCT00812240
3	Masitinib 2nd Line versus Sunitinib in Advanced GIST	Unknown	Active	Masitinib or Sunitinib	NCT01694277
2	Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)	Withdrawn	Not yet activated	Ripretinib plus Binimetinib	NCT05080621